Investigating a new treatment approach for chronic obstructive pulmonary disease (COPD)
Nur77: Novel Mechanistic Insights and Activation in COPD
This study is looking at how a special receptor called Nur77 might help improve lung health for people with chronic obstructive pulmonary disease (COPD) by testing a new treatment that could reduce inflammation and lung damage.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10948904 on NIH RePORTER |
What this research studies
This research focuses on chronic obstructive pulmonary disease (COPD), a condition often caused by smoking, which is becoming increasingly prevalent. The study aims to explore the role of a specific receptor, Nur77, in the progression of COPD and how activating this receptor could potentially improve lung health. By examining the effects of a Nur77 agonist in laboratory models, the research seeks to identify new therapeutic strategies that could halt the disease's progression and improve patient outcomes. The approach includes testing the agonist's impact on inflammation and lung damage associated with COPD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic obstructive pulmonary disease, particularly those experiencing significant symptoms and lung function decline.
Not a fit: Patients with mild COPD or those who are not experiencing significant symptoms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly slow down or even halt the progression of COPD.
How similar studies have performed: Preliminary findings suggest that targeting the Nur77 receptor may be a promising approach, indicating potential success based on similar research efforts.
Where this research is happening
Pittsburgh, United States
- Veterans Health Administration — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Reddy, Raju C — Veterans Health Administration
- Study coordinator: Reddy, Raju C
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.